Monoamine oxidase and its inhibition (Record no. 78116)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03603nam a2200385 a 4500 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 612/.0151/8 |
| 245 10 - TITLE STATEMENT | |
| Title | Monoamine oxidase and its inhibition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication | Amsterdam ; |
| -- | New York : |
| Name of publisher | Elsevier/Excerpta Medica/North-Holland, |
| Year of publication | 1976. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Number of Pages | xii, 415 p. : |
| Other physical details | ill. |
| 490 1# - SERIES STATEMENT | |
| Series statement | Ciba Foundation symposium ; 39 (new ser.) |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Kety, S.S. Introduction.--Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.--Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.--Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.--Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.--Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.--Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.--Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.--Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.--Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.--Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?--Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.--Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.--Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.--Roth, M. et al. The relationship between classification and response to drugs in affective disorders--problems posed by drug response in affective disorders.--Sandler, M. Variations in monoamine oxidase activity in some human disease states.--Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Term | Monoamine oxidase |
| Topical Term | Monoamine oxidase |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bernheim, Molly, |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://site.ebrary.com/lib/rucke/Doc?id=10575452 |
No items available.